Location: Home
  • search
  • go
  • Relate News
  • 12/18/2019Chinese Cancer Drug Market to Surpass $30+ Billion by 2025
  • 12/18/2019HitGen and Mitsubishi Tanabe Enter Into License Agreement
  • 12/18/2019Takeda Aspires to Become A Top Ten MNC Pharma Co. in China
  • 12/17/2019Frontage Acquires CRO BRI Biopharma for Expansion into North America
  • 12/17/2019NMPA/CDE Commits to CDISC Standards
  • 12/17/2019Janssen and Shandong Fontacea Enter Licensing Deal for Anti-IL17A mAb
  • 12/17/2019NHSA Issues Interim Regulation for Government Information Publication
  • 12/17/2019NMPA: China Has Over 1 Mln Registered Pharmacists
  • 12/16/2019NHSA and NHC Issue Joint Notice to Facilitate BMI Access of Negotiated...
  • 12/16/2019NH Reports on Chinese OTC Sleep Aids Market in MAT Q3/2018
  • 12/16/2019BeiGene's Brukinsa Fails to Match AbbVie-J&J Rival Imbruvica in La...
  • 12/16/2019A Few Details on the US-China "Phase One" Trade Deal
  • 12/16/2019The US-China Trade Deal Phase Two - Digital Trade, IP, Cyber Intrusion...
  • 12/13/2019Recent Executive Moves
  • 12/13/2019BeiGene Announces Clinical Data on Anti-PD-1 Tislelizumab in Combo wit...
  • 12/13/2019Here's What's In, What's Out of U.S.-China Trade Deal
  • 12/13/2019ZJ Medicine and Ambrx Present Positive Data from a Phase 1a/1b Trial o...
  • 12/13/2019Granules to Dispose Full Stake in Chinese JV
  • 12/13/2019NMPA and NHC Issues Joint Notice for Vaccine IT Tracing Infrastructura...
  • 12/13/2019Preview of 16 Heavy-weight New Drug Expected to be Approved in China N...
  • 12/13/2019IQVIA: Chinese Hospital Drug Market Up 9.7% in MAT Q3/2019
  • 12/13/2019IQVIA: Chinese Retail Pharmacy Sales Up 1.9% in Q3/2019
  • 12/12/2019ChP Commission Solicits Comments on the draft of “Naming Principles f...
  • 12/12/2019Eli Lilly's Verzenio and Amgen's Blincyto To Be Granted Priority Revie...
  • 12/12/2019Upcoming Event: International Conference on Biosimilars and Biologics
  • 12/12/2019Astrazeneca Rounds Out Stellar China Year - And Beats Roche To The Pun...
  • 12/12/2019Numab and 3SBio's Subsidiary Form Partnership to Develop Novel Multi-s...
  • 12/12/2019NMPA Issues the Guidelines for Aluminum Adjuvant in Preventative Vacci...
  • 12/12/2019AstraZeneca Granted Chinese Approval of Imfinziin for Unresectable Sta...
  • 12/11/2019Avantor Opens Center in Shanghai to Boost Biopharma Innovation in Chin...
  • Page:200/720 Total number of articles:21572: [First][<<] [198] [199] [200] [201] [202] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group